Posts Tagged ‘Nebraska yaz lawyer’
Bayer Reports $1.4 Billion in Yaz and Yasmin SettlementsBayer Pharmaceuticals has announced that it has settled almost 6,700 lawsuits related to its Yaz and Yasmin birth control products. In the $1.4 billion Yaz lawsuit settlement, Bayer did not accept responsibility for their products causing deep vein thrombosis, pulmonary embolisms, or other blood clot injuries. Bayer has yet to reach Yaz and Yasmin settlements in more than 5,400 other cases, of which almost 2,700 have alleged similar injuries. Bayer also announced that a Yaz lawsuit settlement has also been reached in almost 8,800 cases in which plaintiffs claim that Yaz or Yasmin produced gall bladder injuries. The use of the birth control pills has reportedly been linked to the occurrence of Yaz gall bladder disease which can lead to the removal of this organ. In this settlement, Bayer reportedly agreed to settle for payments totaling $24 million. The terms of the settlement include a $2,000 payment to patients who suffered a gallbladder injury and a $3,000 payment to those who had their gall bladders removed. The 8,800 plaintiffs which have acceded to the settlement terms exceeds the 90 percent participation threshold, allowing the settlement to proceed.
Yaz lawsuit settlement for blood clot related injuriesInitially introduced in 2006 in the United States, Yaz and Yasmin were marketed as birth control medications with effectiveness in treating premenstrual syndrome and acne. Yaz and Yasmin act to elevate potassium levels which can produce heart arrhythmias, hyperkalemia, stroke, blood clots, embolisms, hyponatremis, and even death. A study by the British Medical Journal in 2011 reported that Yaz and Yasmin users could double their risk of blood clots compared to alternative birth control drugs.
Bayer’s response to adverse event reportsAs the manufacturer of Yaz and Yasmin, Bayer is responsible for providing adequate warnings to users of their products. In the Yaz lawsuit settlement, many plaintiffs claimed that Bayer utilized deceptive marketing practices which exaggerated benefits and virtually ignored the serious side effects which could result. Some of these Yaz lawsuits alleged that Bayer was negligent in not studying the potentially serious and fatal injuries that could result from Yaz or Yasmin use. Although Bayer did modify its advertising following an FDA study which questioned the safety of Yaz and Yasmin thousands of users may have already suffered blood clots or other serious injuries.
Yaz litigationWhile many of those injured by the oral contraceptives have participated in the Yaz and Yasmin settlements, many more of these lawsuits continue through the legal system. To date more than 11,000 cases related to these products have been filed. Many of these lawsuits have been consolidated into a Yaz multidistrict litigation or MDL currently being litigated in the U.S. District Court of Southern Illinois. Although similar to a class action lawsuit in that legal resources may be pooled, a MDL allows individual plaintiffs to retain control over their lawsuit including the ability to pursue a jury verdict or independent settlement. Bayer is still embroiled in negotiations with more than 5,000 litigants who are seeking a different outcome. While Bayer is attempting to reach a Yaz lawsuit settlement with each of these plaintiffs, it is expected that additional cases will be brought against the German pharmaceutical company. Author: Sarah Klein | Posted In: Yaz Lawsuits August 16, 2013 If you or a loved one is injured by Yaz from a dangerous blood clot call us today
- heart attack,
- pulmonary embolism,
- deep vein thrombosis
- blood clots
- Blood clots
- Deep vein thrombosis
- Heart attack
- Pulmonary embolism
There is Currently a Bayer Payout For Yaz LawsuitsBayer, the manufacturer of Yaz, has paid $1.18 billion to 5,700 women who suffered fatal injuries linked to the company’s Yaz Birth Control Yaz pills. There are more than 10,000 lawsuits pending, and the company is considering additional settlements. File your Yaz lawsuit today. Do not be left out of what you deserve.
Yaz and Yasmin Blood Clot AlertWomen who have taken Yaz, Yasmin, Beyaz or Ocella are at risk for fatal blood clots , according to a 2012 warning from the Food and Drug Administration (FDA). Progestin drospirenone, can cause deep vein thrombosis, heart attacks, pulmonary embolism and stroke, all of which can be fatal. If Yaz, Yasmin, Beyaz or Ocella caused blood clots, stroke, DVT or pulmonary embolism join the thousands of other women seeking justice from the maker of these contraceptives.
Bayer Pays More Than $1 Billion to VictimsYaz, Yasmin, Ocella have a risk of:
- Deep vein thrombosis: A serious blood clot in the leg that can travel
- Pulmonary embolism: A blood clot travels to the lungs and a pulmonary embolism occurs
- Heart attack: The blood clot travels and enters the heart
- Stroke: The blood clot travels to the brain.
Multi-district litigations have formed for Yaz blood clot injuryThe Yaz cases are similar cases combined for pre-trial matters. Get your Yaz lawyer today
Yaz Lawsuit News Updates By Yaz Birth Control Pills HelplineYaz lawyers continue file Yaz lawsuits for victims of blood clots, stroke, deep vein thrombosis, and pulmonary embolism. The latest Yaz news reports that settlement agreements have been reached in approximately 5,700 claims involving Yaz, Yasmin, Ocella, and Gianvi. These harmful birth control pills have been the subject of lawsuits since 2009. The Yaz Birth Control Pills Helpline encourages injured women to speak to an experienced Yaz lawyer right away as statute of limitations by state could effect your lawsuit. Bayer’s quarterly newsletter says that Bayer would continue to investigate claims and potentially offer settlements to victims of blood clot injuries, such as stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE). Our readers with a potential Yaz, lawsuit should call us to protect their legal rights. The Yaz lawyers at Yaz Birth Control Pills Helpline are here to discuss your Yaz lawsuit.
Yaz Gallbladder Settlements AnnouncedAccording to the terms of the agreement, Bayer will pay $2,000 to each complainant that experienced gallbladder conditions from the use of Yaz/Yasmin, and $3,000 to each person that required gallbladder removal surgery for the same reason.
Now we have two birth control devices under scrutiny and both manufactured by Bayer Pharmaceuticals. Bayer is the manufactuer of Yaz a birth control pill with warnings for blood clots, pulmonary embolism, deep vein thrombosis and strokes in young women. Bayer promoted the birth control pills as a way to easy freedom but, neglected to offer the problematic side effects. Now we have the Mirena IUD. The Mirena was also promoted for freedom but with it came uterine and organ perforation and other side effects
Lawyers are filing lawsuits against Bayer for these harmful side effects and in fact Bayer has offered the forst round od settlements for Yaz.
The New York Times recently reported on the heath concerns surrounding Yasmin and Yaz.
Side effects suffered by some women who take Yaz or Yasmin include:
- Deep vein thrombosis
- Gall bladder disease
- Pulmonary embolism
- Blood clots
- Heart attack
Mirena IUD Complications include:
- Organ perforations
- Device migration
- Embedment in the uterine wall
- Uterine perforations
- Intestinal perforations or obstruction
- Pelvic Inflammatory Disease
- Ectopic Pregnancy
If you a wife, girlfriend, friend, sister, daughter, mother or anyone you know has been injured by either of these devices call us today.
Yaz Manufactured by Bayer Pharmaceuticals was one of the most popular birth control pills. Unfortunately due to the ingredients has been shown to cause blood clots, pulmonary embolism, blood clots, stroke, deep vein thrombosis and in some cases fatal complications.
The Yaz Birth Control Pills Helpline is launching a nationwide campaign to locate women who suffered a blood clot after taking the birth control pill Yaz. There are state statute of limitations in effect and time may be limited to file your Yaz lawsuit.
I you, a daughter, wife, sister or friend has suffered a blood clot, Deep Vein Thrombosis, stroke or Pulmonary Embolism after taking Yaz or Yasmin contact the Yaz Birth Control Pills Helpline to be connected with a Yaz lawyer to see if you have a Yaz lawsuit. The first payouts for Yaz blood clots have begun, The Yaz Birth Control Pills Helpline does not want any woman injured by Yaz to be left pour or find out it is too late.
On October 25, 2011, the British Medical Journal published a study from the University of Copenhagen linking the hormone in Yaz to blood clots. On October 27, 2011, the FDA released its own study entitled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" showing drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.
On May 31, 2012, the QuarterWatch report from the Institute for Safe Medicine Practices ranked Yaz and Yasmin second highest in 2011 for the number of complications reported to the FDA.
A Yaz Multi-District Litigation has been assignned in Illinois to consolidate these cases. The legal term for the Yaz lawsuits is Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois). More than 10,000 women have filed a Yaz blood clot claim.
Bayer has now begun settlle Yaz lawsuits with the first payouts at an average of $212,000 for each injured claimant. Bayer has set aside up to $610 million to settle the Yaz blood clot lawsuits. If you have a blood clot resulting in pulmonary embolism, deep vein thrombosis, or stroke from Yaz now would be the time to file your Yaz lawsuit claim if you have not done so. Time is limited for anyone with resulting blood clots, stroke, Deep Vein Thrombosis or pulmonary embolism after taking Yaz.
The Yaz Bitrth Control Pills Helpline Outreach will begin with the major and most populated cities in the U.S. to reach out to women injured by Yaz and connect them to a n experienced drug litigation, mass tort lawyer.
An initial outreach to locate women with blood clots from Yaz will be in New York, Los Angeles, Chicago, Houston, Philadelphia, Phoenix, San Antonio, San Diego, Dallas, and San Jose,
The next will include:Jacksonville, Indianapolis, San Francisco, Austin, Columbus, Fort Worth, Charlotte, Detroit, and El Paso,and continue continue to Baltimore, Boston, Seattle, Washington, DC, Denver, Milwaukee, Portland and, Las Vegas,
Women who have been injured with Blood Clots by Yaz will also be introduced to the Yaz Birth Control Pills Helpline in Oklahoma City, Albuquerque, Tucson, Fresno, Sacramento, Long Beach, Kansas City, Mesa, Virginia Beach, Atlanta, Colorado Springs, Omaha, Raleigh, Miami, Cleveland, Tulsa, Oakland, Minneapolis, Wichita, and Arlington,
The Yaz birth control pills lawyers of the Yaz Helpline are filing lawsuits for women with strokes, pulmonary embolism and blood clots from Yaz.
If you took Yaz and suffered a blood clot related injury such as a DVT, a pulmonary embolism, a stroke or other blood clot related injury it is not too late to file a Yaz Lawsuit. Please contact us immediately so that we can arrange a free consultation with a Yaz Lawyer regarding your potential Yaz Lawsuit. Bayer’s Yasmin lawsuit settlement have risen to $402.6 million
By Jef Feeley and Naomi Kresge on July 31, 2012
Bayer AG (BAYRY) said settlements of U.S. lawsuits over claims that its Yasmin line of birth-control pills caused blood clots in women have increased to more than $402 million.
Bayer, based in Leverkusen, Germany, has resolved almost 1,900 cases (BAYRY) in which it’s alleged that its Yasmin and Yaz contraceptives caused clots that can lead to heart attacks and strokes, the company said today in a stockholders’ newsletter. Bayer said it has paid $402.6 million in settlements of one category of clot cases, for an average of about $212,000 a case.
Bayer also more than doubled its reserve for Yaz cases, setting aside 496 million euros ($610.5 million), the company said. The drugmaker set aside a total of about 200 million euros in 2010 and 2011, according to securities filings.
“We believe we have made appropriate provisions for most of the cases we consider to be worthy of settlement with these accounting measures,” Bayer officials said in an e-mailed statement.
Drug-industry analysts, such as JPMorgan Chase & Co.’s Richard Vosser, have said Bayer may have to pay more than 2 billion euros to resolve all the cases over the pills.
In April, the U.S. Food and Drug Administration ordered Bayer and other contraceptive makers to strengthen blood-clot warnings on their products.
Pills like Bayer’s Yasmin, which contain a synthetic hormone called drospirenone, will have warning labels saying researchers found they may triple the risk for clots.
The FDA examined data on more than 835,000 women who took pills containing drospirenone, including Bayer’s Yasmin line, according to the FDA report. Yasmin was the No. 4 oral contraceptive in the U.S. in 2011, with 4.6 percent of the market as of September, according to data from IMS Health.
Bayer’s contraceptives generated $1.1 billion in sales in 2011, making them the drugmaker’s biggest-selling drugs after Betaseron, a multiple sclerosis medication and Kogenate, a medicine to treat hemophilia, according to data compiled by Bloomberg.
Bayer released its stockholders’ newsletter on the same day it raised its 2012 revenue and earnings forecasts, citing increased sales of crop chemicals and drugs as well as favorable exchange rates.
Bayer said revenue will gain about 4 percent to 5 percent this year to 39 billion euros to 40 billion euros, excluding currency and portfolio changes. The company previously forecast a sales increase of about 3 percent.
Bayer’s American depositary receipts (BAYRY), each representing one ordinary share, rose 1.92 percent to $75.95 in over-the counter trading today in New York. Shares in Germany climbed 1.3 percent to 61.60 euros.
The $610.5 million Bayer set aside this quarter is to pay the company’s costs beyond what insurance will cover for legal fees and accords, including cases that haven’t been settled, a spokesman, Guenter Forneck, said in a telephone interview today. Bayer isn’t disclosing the amount of its insurance coverage.
In the newsletter, the drugmaker’s executives said Bayer faced more than 12,000 lawsuits over the Yasmin line of contraceptives, including claims that they caused blood clots in some women and damaged gallbladders in others.
So far, Bayer has agreed to settle 1,877 cases in which women blame the company’s contraceptives for causing clots in their veins. “Such injuries are alleged in about 6,000 claims and therefore in fewer than half the cases served to date,” Bayer officials said in the publication.
“This indicates they are making progress putting these Yaz suits over the vein clots behind them,” Carl Tobias, who teaches product-liability law at the University of Richmond in Virginia, said in a phone interview.
Michael Burg, a Denver-based lawyer for women suing over the Yasmin line, said Bayer has refused to settle cases alleging the contraceptives also caused clots in women’s arteries.
“Those cases involve some of the more serious injuries and we look forward to trying them,” he said in a telephone interview today.
The drugmaker is rejecting women’s claims that the contraceptives damaged their gallbladders or caused gallstones, Burg said.
Wave of Litigation
Since 2009, the German drugmaker has faced a wave of litigation over the birth-control pills. Lawyers suing the company cited FDA reports of at least 50 deaths tied to the pills from 2004 to 2008. Plaintiffs’ lawyers contend in court filings that Bayer officials marketed the contraceptives for unapproved uses and misled women about their risks.
The cases filed in federal courts were consolidated before U.S. District Judge David Herndon in East St. Louis, Illinois, for pretrial proceedings.
Herndon scheduled a series of trials so juries could begin weighing claims that Bayer and its units marketed Yaz and other contraceptives as safer than rivals’ products while knowing they posed a higher clot risk.
At Bayer’s suggestion, Herndon called in Stephen Saltzburg, a George Washington University law professor, to serve as a mediator. Saltzburg’s job was to explore the possibility of “settlements in this litigation,” Herndon said in a December order.
The judge put the trial schedule on hold while Saltzburg met with lawyers for the drugmakers and former Yaz users.
Saltzburg said earlier this month that settlement talks are continuing between the company and women’s lawyers and progress is being made in resolving cases.
“There are always some holdouts, but I think we will settle the bulk of these cases next year,” Saltzburg told an Illinois newspaper July 5.
The case is In re Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Product Liability Litigation, 09-md-02100, U.S. District Court, Southern District of Illinois (East St. Louis).